Infection
571
32
45
334
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
64 trials with published results (11%)
Research Maturity
334 completed trials (58% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.7%
38 terminated out of 571 trials
89.8%
+3.3% vs benchmark
18%
103 trials in Phase 3/4
19%
64 of 334 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 334 completed trials
Clinical Trials (571)
Biomarkers in Infection
A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients
Diagnosis and Management of Inflammatory and Infectious Diseases
Cholera Toxin B Subunit (CTB) Administered by Mucosal Way in Healthy Adult Volunteer
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
Serum Potassium Prediction Using Machine Learning and Single-lead ECG
Pharmacological Comparison of Continuous and Intermittent Infusions of Cloxacillin
Active Surveillance Cultures for Multidrug Resistant Gram-Negative Organisms at an Acute Care Hospital
Home Hospital for Suddenly Ill Adults
Prediction of 30-Day Readmission Using Machine Learning
Prediction of Patient Deterioration Using Machine Learning
Prediction of Expected Length of Hospital Stay Using Machine Learning
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
Copper Supplementation in Cirrhosis
Rapid Response Home Care as an Alternative to Acute Admission
PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2
Validation of Drug Assays in Various Biological Matrices
Early Sepsis Recognition Tool
BLOOM: Pragmatic Feasibility Trial
Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial)